Last reviewed · How we verify

NCT05718245

HEPA, PM2.5, and Cardiometabolic Health

Recruiting now NA Last updated 1 August 2025
What this trial tests

NA trial testing HEPA filter in Air Pollution in 52 participants. Currently enrolling.

Timeline
15 March 2023
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorUniversity of Southern California
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeprevention
Enrollment52
Start date15 March 2023
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Southern California

Who can join

Adults 65 to 84, any sex, with Air Pollution or Cardiometabolic Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Fine particulate matter levels and HEPA filtration in Los Angeles homes during a wildland-urban-interface fire.
    Chen R, Lin Y, Liao J, Qiu C, et al · · 2026 · PMID 41550628 · DOI 10.1038/s44407-025-00042-5

Verify or expand the search:

Other trials of HEPA filter

Trials testing the same drug.

Other recruiting trials for Air Pollution

Currently open trials in the same condition.

Other University of Southern California trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05718245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing